Atea Pharmaceuticals, Inc. — Director's Dealing 2025

Feb 25, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Atea Pharmaceuticals, Inc. (AVIR)
CIK: 0001593899
Period of Report: 2025-02-20

Reporting Person: Kirsch Arthur S (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-02-20	Stock Option (Right to Buy)	$3.14	A	164800	Acquired	2035-02-19	Common Stock (164800)	Direct

Footnotes

F1: The option vests and becomes exercisable in thirty-six (36) equal monthly installments following February 20, 2025 such that the option is fully vested on February 20, 2028.